BIOGEN INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.9 | $9.7 | $9.8 | $10.2 | $11.0 |
| Operating income | — | — | — | — | $2.8 |
| Net income | $1.3 | $1.6 | $1.2 | $3.0 | $1.6 |
| Balance Sheet | |||||
| Total debt | $6.6 | $6.6 | $7.2 | — | — |
| Cash Flow Statement | |||||
| Free cash flow | $2.1 | $2.7 | $1.3 | $1.1 | $3.4 |
| Share repurchases | — | $0.0 | $0.0 | $0.8 | $1.8 |
Shares outstanding 147.8M · Free float 99.9%
Annual filing data through FY ended December 31, 2025; float as of September 22, 2026.